William Myers, DPM
Primary Podiatric Medicine · Conway, SCNPI 1457316861
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 33.1% of the total. 2025 is the largest year on record at $1,424, more than ten times the $22 reported in 2019.
Across 63 payments — averaging $65.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Peerless Surgical Inc.$1K
- Medtronic$258
- Linvatec Corporation$237
- Imbed Biosciences Inc.$207
- Kerecis Limited$146
- plus $694 from 17 others
What the payments were for
- Travel & lodging$1,03125%
- Food & beverage$1,91646%
- Education$1,20029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 9 | $1,374 |
| Peerless Surgical Inc. | 2 | $1,231 |
| Medtronic | 4 | $258 |
| Linvatec Corporation | 2 | $237 |
| Imbed Biosciences Inc. | 11 | $207 |
| Kerecis Limited | 6 | $146 |
| Amgen | 4 | $141 |
| Paratek Pharmaceuticals, Inc. | 5 | $117 |
| GRT US Holding, Inc. | 2 | $95 |
| Misonix Inc | 1 | $54 |
| Smith+Nephew | 2 | $38 |
| Terumo BCT, Inc. | 1 | $37 |
| Heron Therapeutics, Inc. | 3 | $36 |
| Paragon 28, Inc. | 1 | $25 |
| Merck | 2 | $22 |
| Acumed LLC | 1 | $20 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Polynovo North America LLC | 1 | $17 |
| Next Science LLC | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Triad Life Sciences Inc. | 1 | $16 |
| Nevro Corp. | 1 | $15 |
| Medela LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty$680
- 5MS$474
- LAPIPLASTY SYSTEM 1$351
- INTELLIS ADAPTIVESTIM$120
How this compares
Too few primary podiatric medicine providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 13 | $480 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 81 | $424 |
| Terbinafine Hcl | 61 | $343 |
| Diclofenac Sodium | 14 | $295 |
| Doxycycline Hyclate | 43 | $281 |
| Meloxicam | 90 | $173 |
| Levofloxacin | 25 | $66 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $59 |
| Promethazine Hcl | 22 | $38 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Conway
- Robert EzewuiroLancaster$21K
- Subodh ChoudharyGreenville$9K
- Katlin O'HaraLancaster$6K
- Michael JordanSpartanburg$6K
- Constantine CanoutasGreenville$6K
- Matthew FernandezCharleston$5K
- Sarah SchipperGreenville$3K
- Nicholas VarakinGreenville$2K
- Bradley LindstromMauldin$2K
- Dwayne JacobusColumbia$559
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.